Bouchahda, M., Boige, V., Smith, D., Karaboué, A., Ducreux, M., Hebbar, M., . . . Tumolo, S. (2016). Early tumour response as a survival predictor in previously- treated patients receiving triplet hepatic artery infusion and intravenous cetuximab for unresectable liver metastases from wild-type KRAS colorectal cancer.
Citação do estilo Chicago (17ª ed.)Bouchahda, M., et al. Early Tumour Response as a Survival Predictor in Previously- Treated Patients Receiving Triplet Hepatic Artery Infusion and Intravenous Cetuximab for Unresectable Liver Metastases from Wild-type KRAS Colorectal Cancer. 2016.
Citação MLA (8ª ed.)Bouchahda, M., et al. Early Tumour Response as a Survival Predictor in Previously- Treated Patients Receiving Triplet Hepatic Artery Infusion and Intravenous Cetuximab for Unresectable Liver Metastases from Wild-type KRAS Colorectal Cancer. 2016.